Therapy Areas: Autoimmune
Hansa Medical widens loss in Q2 2018
20 July 2018 - Hansa Medical AB (STO:HMED), a biopharmaceutical company developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases, reported on Thursday a net loss of ...
Landos Biopharma Doses First Subjects in Clinical Trial of Investigational IBD Treatment
18 July 2018 - - Blacksburg, Virginia-based clinical-stage biopharmaceutical company Landos Biopharma, Inc. has dosed the first healthy subjects in a phase 1 clinical study of BT-11, a first-in-class,...
HSS wins USD5.6m grant in support of translational research and major musculoskeletal conditions
17 July 2018 - Academic medical centre company Hospital for Special Surgery (HSS) reported on Monday the receipt of an additional USD5.6m in grant from The Tow Foundation for translational research as...
Compass Therapeutics Closes Final USD 49m of USD 132m Financing
16 July 2018 - - Cambridge, Massachusetts-based immune system biotech company Compass Therapeutics has closed the final USD 49m of its USD 132m series A financing, the company said.
This financi...
Mallinckrodt Completes Database Studies on TKA Recovery After IV Acetaminophen
13 July 2018 - - Staines-upon-Thames, UK-based specialty pharmaceutical company Mallinckrodt plc (NYSE: MNK) has completed two retrospective analyses that provide health economic insights on use of Of...
Saniona announces receipt of EUR4.0m milestone payment from Boehringer Ingelheim
12 July 2018 - Saniona AB (STO:SANION), a biotechnology company within ion-channel research, announced on Thursday the selection by Boehringer Ingelheim of the first candidate for pre-clinical and cli...